Collaboration Details

Print  Close


Title of Collaborative Activity:

Developmental Considerations of Antifungal Drugs to Address Unmet Medical Need

Description of Collaborative Activity:

A virtual public workshop sponsored by FDA regarding the development of new therapies to address unmet medical need for the treatment of infections due to invasive molds and Candida auris. Discussions will focus on the current state and clinical trial design considerations for developing new therapies for these infections.

Type of Collaborative Activity:

Meeting/ Workshop

Year the Collaborative Activity Originated:

2020

NIH Participating Institutes/Centers/Office of the Director:

NIAID

HHS Agency Collaborators on this Activity:

FDA